Flecainide acetate and Injection site pain - a phase IV clinical study of FDA data

Summary:

Injection site pain is reported as a side effect among people who take Flecainide acetate (flecainide acetate), especially for people who are female, 60+ old, also take Xarelto, and have Acromegaly.

The phase IV clinical study analyzes which people have Injection site pain when taking Flecainide acetate. It is created by eHealthMe based on reports of 6,177 people who have side effects when taking Flecainide acetate from the FDA, and is updated regularly.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.

What is Injection site pain?

Injection site pain is found to be associated with 1,873 drugs and 1,943 conditions by eHealthMe. Check the latest studies of Injection site pain.

On Jul, 20, 2026

6,177 people reported to have side effects when taking Flecainide acetate.
Among them, 40 people (0.65%) have Injection site pain.

Could Flecainide acetate cause Injection site pain?

Among these 40 people:

What is the gender of people who have Injection site pain when taking Flecainide acetate? *

female: 78.95 %
male: 21.05 %

What is the age of people who have Injection site pain when taking Flecainide acetate? *

What are other drugs people take besides Flecainide acetate? *

What are other side effects people have besides Injection site pain? *

Injection Site Bruising: 18 people, 45.00%
Pain: 17 people, 42.50%
High Blood Pressure: 17 people, 42.50%
Weakness: 16 people, 40.00%
Gait Disturbance: 15 people, 37.50%
Joint Pain: 15 people, 37.50%
Cough: 15 people, 37.50%
Joint Swelling: 14 people, 35.00%
Headache (pain in head): 14 people, 35.00%
Head Injury: 14 people, 35.00%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 13 people, 32.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 15.00%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 5 people, 12.50%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 7.50%
Pain: 3 people, 7.50%
Asthma: 3 people, 7.50%
Acquired Haemophilia (bleeding disorder disease): 2 people, 5.00%
Osteoporosis (bones weak and more likely to break): 2 people, 5.00%
Bleeding Disorders: 2 people, 5.00%
High Blood Pressure: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Flecainide acetate and have Injection site pain?

- Check whether Injection site pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flecainide acetate:

Flecainide acetate (7,176 reports)

Browse all side effects of Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site pain:

Injection site pain (1,873 drugs)

Browse all the conditions that are associated with Injection site pain:

Injection site pain (1,943 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on flecainide acetate (the active ingredients of Flecainide acetate) and Flecainide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.